University Of Utah
Clinical trials sponsored by University Of Utah, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Video meditation or standard support? study tests best way to ease Post-Surgery pain Results expected Sep 2026 (estimated)
- Double surgery combo may help glaucoma patients see better outcomes Results expected Sep 2026 (estimated)
- Can Lab-Grown tumors stop breast cancer from coming back? Results expected Sep 2026 (estimated)
- Can financial coaching ease the burden on dementia caregivers? Results expected Oct 2026 (estimated)
- Personalized radiation: scans could guide higher doses to aggressive tumors Results expected Oct 2026 (estimated)
-
Can a Two-Drug combo outsmart resistant breast and ovarian cancers?
Disease control Stopped earlyResearchers are testing whether combining ribociclib and belinostat can help people with metastatic triple-negative breast cancer or recurrent ovarian cancer. The trial starts by finding the safest dose of the drug pair, then expands to see how well it works in breast cancer pati…
Phase 1 • Sponsor: University of Utah • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New staggered drug combo aims to outsmart lung cancer
Disease control Stopped earlyThis phase II study tests two staggered schedules of the immunotherapy drug durvalumab combined with standard chemotherapy (pemetrexed and carboplatin) in 43 adults with advanced non-squamous non-small cell lung cancer. The goal is to see if changing the timing of the drugs impro…
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for myelofibrosis patients who failed standard therapy?
Disease control Stopped earlyThis study tested a drug called selinexor in 17 people with a rare bone marrow cancer (myelofibrosis) that did not respond to or could not tolerate standard JAK inhibitor treatments. The main goal was to see if the drug could shrink an enlarged spleen by at least 35%. The trial w…
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug combo trial for tough pancreatic cancer shows early promise
Disease control Stopped earlyThis early-stage trial tested a combination of two drugs, trametinib and hydroxychloroquine, in 25 adults with advanced pancreatic cancer that could not be removed by surgery. The main goal was to find the safest dose and understand side effects. The study was stopped early, so r…
Phase 1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New ultrasound technique aims to catch kidney transplant trouble sooner
Diagnosis Stopped earlyThis study tested a special ultrasound that uses a contrast dye to get clearer images of a new kidney after transplant. The goal was to see if this method could help doctors find early signs of problems like rejection or slow function. The study was small (20 people) and was stop…
Phase 1 • Sponsor: University of Utah • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Cancer prevention study for pacific islanders ends early with just 2 volunteers
Prevention Stopped earlyThis study aimed to see if changing meal timing could lower cancer risk in Native Hawaiian and Pacific Islander women. Only 2 women joined before the study was stopped early. The goal was to find a culturally fitting way to reduce cancer risk factors like obesity and diabetes in …
Sponsor: University of Utah • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Could a High-Tech headband clear the fog of chemo brain?
Symptom relief Stopped earlyThis study tests whether a headband with special semiconductors can help with memory and thinking problems (often called 'chemo brain') in people who have had breast or gynecologic cancer. About 50 participants will wear either the active headband or a placebo version for 18 hour…
Phase 2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Massage therapy tested as fatigue fix for prostate cancer survivors
Symptom relief Stopped earlyThis phase II trial tested whether Swedish massage can reduce fatigue in men who have had radiation for prostate cancer. The study enrolled 28 men aged 45 and older who reported significant fatigue. Researchers measured fatigue levels and inflammatory markers before and after mas…
Phase 2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New heat procedure may offer better relief for chronic back pain
Symptom relief Stopped earlyThis study compared two heat-based procedures to treat pain from the sacroiliac joint, a common cause of low back pain. One method uses a newer device to create larger burns, while the other uses a standard technique. The trial enrolled 20 adults with long-term pain who had not i…
Phase 4 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a Plant-Based pill soothe radiation side effects in prostate cancer?
Symptom relief Stopped earlyThis study looked at whether a supplement called Q-Urol (made from quercetin, bromelain, rye flower pollen, and papain) could reduce prostate inflammation caused by radiation therapy in men with localized prostate cancer. Ten men who had brachytherapy (with or without other radia…
Phase 2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC